FDA Inspection
Lattice IncLattice Inc – FDA Inspection, May 22, 2025
Record Details
This FDA Inspection record concerns Lattice Inc, with an inspection on May 22, 2025, issued by the Chicago District Office, covering biologics.
View Company Profile
ID · e08fce41-a667-4e11-a410-cb26e8e09f55
Inspection Facts
- Inspection number
- 1270487
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
7- 21 CFR 801.20(a)Label to bear a unique device identifier
- 21 CFR 820.100(a)Lack of or inadequate procedures
- 21 CFR 820.120Lack of or inadequate procedures for labeling
- 21 CFR 820.22Quality audits - Lack of or inadequate procedures
- 21 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
- 21 CFR 820.40(a)Document review, approval by designated individual
- 21 CFR 820.50Purchasing controls, Lack of or inadequate procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lattice Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 17, 2020 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| March 12, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| December 6, 2012 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Lattice Inc
- FDA Inspection 1117176 - 2020-01-17
- FDA Inspection 917726 - 2015-03-12
- FDA Inspection 811199 - 2012-12-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.